See analyst estimates and all valuation multiples for Small Molecules
Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
$3.2B | 7.2x | 19.5x | |
$3.1B | 17.6x | 57.1x | |
$2.2B | 19.4x | -31.6x | |
$2.1B | 2.8x | 15.9x | |
$1.8B | 0.7x | 5.7x | |
$1.8B | 7.1x | 17.4x | |
$1.7B | 11.0x | -5.4x | |
$1.5B | 57.6x | -41.9x | |
$1.2B | 5.3x | 15.8x | |
$1.1B | 5.1x | 25.1x | |
$801M | n/a | n/a | |
$787M | n/a | n/a | |
$760M | 3.5x | 119.9x | |
$635M | 3.2x | 13.6x | |
$584M | 6.9x | 20.3x | |
$356M | 4.8x | n/a | |
$344M | 340.0x | -2.0x | |
$319M | 1.7x | 8.9x | |
$209M | n/a | n/a | |
$182M | n/a | -8.5x | |
$166M | 6.1x | -6.6x | |
$127M | 1767.1x | -27.4x | |
$106M | 1.1x | -10.3x | |
$71.4M | 1.4x | n/a | |
$33.3M | n/a | -0.2x | |
$16.6M | 1.3x | n/a | |
-$27.6M | -34.0x | 0.3x | |
-$32.6M | -0.4x | 0.3x | |
-$37.1M | -8.3x | n/a | |
-$37.2M | n/a | n/a | |
-$46.3M | -1.5x | 0.4x | |
-$130M | n/a | n/a | |
-$243M | -5.6x | 1.3x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules